SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs Fetal EchoScan
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope, focusing on differentiating physiological from pathological sounds. In contrast, Tool B is an AI-powered ultrasound screening software specifically designed for the prenatal detection of congenital heart defects. While both are FDA-cleared AI tools in cardiology, they utilize different diagnostic modalities and target distinct patient populations and clinical use cases.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
SensiCardiac Mobi integrates by connecting to a user-provided electronic stethoscope and using a mobile application to acquire, record, and analyze acoustic heart signals during a physical exam, acting as decision support. Fetal EchoScan integrates seamlessly with existing ultrasound machines and reporting solutions, providing real-time AI analysis and alerts on a cart-side tablet display during prenatal ultrasound examinations.
SensiCardiac Mobi primarily functions as a mobile application for data capture and display of heart sound analysis, without explicit mention of direct EHR integration capabilities. Fetal EchoScan offers seamless integration with existing ultrasound machines and reporting solutions through DICOM compatibility, which facilitates the transfer of imaging data and potentially integrates with systems that consume DICOM.
SensiCardiac Mobi uses its proprietary Sensi Diagnostic Heart Murmur Algorithm to analyze acoustic heart signals, aiming to distinguish between physiological and pathological murmurs and identify S1, S2, and suspected murmurs, thereby supporting physician assessment. Fetal EchoScan enhances diagnostic accuracy by providing AI-driven support for automated detection of congenital heart defects and is designed to reduce false-negative and false-positive errors during prenatal ultrasound screenings.
SensiCardiac Mobi is designed for use in Cardiology, Internal Medicine, and Pediatrics to assist physicians in diagnosing heart murmurs in patients by analyzing acoustic heart signals. Fetal EchoScan is specifically tailored for Cardiology, Maternal-Fetal Medicine, and Radiology specialties, providing AI-powered ultrasound screening for the prenatal detection of congenital heart defects.
SensiCardiac Mobi operates as a mobile application that complements physician assessment, requiring familiarity with electronic stethoscopes and a mobile interface for data capture and display. Fetal EchoScan aims to optimize workflow and provide real-time guidance during ultrasound scans, suggesting a design intended to integrate smoothly with existing practices and potentially offer rapid time-to-value through faster reading times and standardized exams.
SensiCardiac Mobi acquires and records acoustic heart signals, which suggests a capability for data logging that could support audit trails for clinical review. Fetal EchoScan ensures exam completeness and integrates with reporting solutions via DICOM, which typically includes mechanisms for tracking and auditing imaging data.
More Comparisons
Backers
Who funded each tool's parent company.